✦ LIBER ✦

Increased urinary tribulin output in generalised anxiety disorder

✍ Scribed by Angela Clow; Vivette Glover; M. Sandler; J. Tiller

Publisher: Springer
Year: 1988
Tongue: English
Weight: 336 KB
Volume: 95
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf00181951

No coin nor oath required. For personal study only.

✦ Synopsis

Urinary output of an endogenous monoamine oxidase inhibitor and benzodiazepine receptor binding inhibitor (tribulin) was raised in a group of patients with generalised anxiety disorder compared with controls. Tribulin levels remained relatively constant in individual patients over the 6-week period of observation, mean values remaining high even after reduction of anxiety following non-drug behaviour therapy.

📜 SIMILAR VOLUMES

Effect of short-term SSRI treatment on c

Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder

✍ Karin Mogg; David S. Baldwin; Paul Brodrick; Brendan P. Bradley 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 81 KB

Effect of short-term SSRI treatment on c

Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder

✍ Karin Mogg; David S. Baldwin; Paul Brodrick; Brendan P. Bradley 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 81 KB

Rationale: There is considerable evidence showing that individuals with generalised anxiety disorder (GAD) selectively process threat-related information, e.g. they have a bias to interpret ambiguous information in a threat-related manner. Cognitive theories of anxiety, which provide the basis of co

Paroxetine augmentation in patients with

Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo

✍ Sara I. J. Schutters; Harold J. G. M. van Megen; J. Frederieke Van Veen; Koen R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract ## Objectives The aim of the study was to investigate if combination of mirtazapine with paroxetine causes a greater therapeutic effect and less sexual side effects than paroxetine monotherapy in social anxiety disorder (SAD). ## Methods Twenty one patients with generalised SAD, non‐

Generalised anxiety disorder in Singapor

Generalised anxiety disorder in Singapore: prevalence, co-morbidity and risk factors in a multi-ethnic population

✍ Leslie Lim; Tze Pin Ng; Hong Choon Chua; Peak Chiang Chiam; Vivien Won; Theresa 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 121 KB

Comorbidity and risk-patterns of depress

Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study

✍ R. A. Schoevers; A. T. F. Beekman; D. J. H. Deeg; C. Jonker; W. van Tilburg 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## Background Depression and generalised anxiety disorder frequently overlap. The question remains unresolved whether these are specific disorders, or that they represent different dimensions of a single disorder. Although both are highly prevalent disorders in this age group, studies

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial